市場調査レポート
商品コード
1250861
非抗菌性細菌治療市場 - 技術、市場、戦略、予測Non-Antibiotic Bacterial Therapeutics - Technologies, Markets, Strategies & Forecasts |
非抗菌性細菌治療市場 - 技術、市場、戦略、予測 |
出版日: 2023年04月04日
発行: Greystone Research Associates
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
|
当レポートでは、世界の非抗菌性細菌治療市場について調査し、市場の概要とともに、市場のアンメットニーズ、技術動向、規制と基準、市場に参入する企業のプロファイルを提供しています。
‘Non-antibiotic Bacterial Therapeutics ’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for non-antibiotic therapeutic substances that can treat bacterial infections that are resistant to many or most available antibiotics. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides currently undergoing clinical trials. The specificity of antibodies, and the inability of bacteria to develop resistance against them, make antibodies attractive, albeit expensive, alternative therapeutic agents. Bacteriophages have been used for therapy in some parts of the world. Antimicrobial peptides have long been considered as potential replacements for antibiotics but with limited success. Synthetic peptides and synthetic Antibiotic membrane-active agents might herald a shift in treatment options.